Vaxil Announces 2021 Reseach and Development Strategy and Progress

Ads

You May Also Like

Myriad Presents Two New Studies at the Western Section of the American Urological Association

New Data Demonstrate the Clinical Performance of the Prolaris® and myRisk® Hereditary Cancer Genetic ...

Arch Biopartners Initiates Manufacturing Process for Metablok

TORONTO, ONTARIO--(Marketwired - Oct. 10, 2017) - Arch Biopartners, Inc., (Arch or the Company) ...

Loxo Oncology Announces Second Quarter 2016 Financial Results

STAMFORD, Conn., Aug. 03, 2016 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical ...